7-Hydroxystaurosporine
| Internal ID | 5e2dfb6c-e37b-4621-9f0d-e55b8c2c1004 |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | (2S,3R,4R,6R,18R)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one |
| SMILES (Canonical) | CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(NC6=O)O)NC)OC |
| SMILES (Isomeric) | C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)[C@H](NC6=O)O)NC)OC |
| InChI | InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27-,28+/m1/s1 |
| InChI Key | PBCZSGKMGDDXIJ-HQCWYSJUSA-N |
| Popularity | 826 references in papers |
| Molecular Formula | C28H26N4O4 |
| Molecular Weight | 482.50 g/mol |
| Exact Mass | 482.19540532 g/mol |
| Topological Polar Surface Area (TPSA) | 89.70 Ų |
| XlogP | 2.70 |
| Atomic LogP (AlogP) | 3.84 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 3 |
| Rotatable Bonds | 2 |
| UCN-01 |
| Ucn 01 |
| 112953-11-4 |
| KRX-0601 |
| UCN01 |
| UCN-02 |
| (5s,6r,7r,9r,16r)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one |
| NSC-638850 |
| 7BU5H4V94A |
| NSC638850 |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8044 | 80.44% |
| Caco-2 | - | 0.6293 | 62.93% |
| Blood Brain Barrier | - | 0.5250 | 52.50% |
| Human oral bioavailability | - | 0.5571 | 55.71% |
| Subcellular localzation | Nucleus | 0.4033 | 40.33% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8722 | 87.22% |
| OATP1B3 inhibitior | + | 0.9399 | 93.99% |
| MATE1 inhibitior | - | 0.6800 | 68.00% |
| OCT2 inhibitior | - | 0.7359 | 73.59% |
| BSEP inhibitior | + | 0.9503 | 95.03% |
| P-glycoprotein inhibitior | + | 0.7349 | 73.49% |
| P-glycoprotein substrate | + | 0.8012 | 80.12% |
| CYP3A4 substrate | + | 0.7145 | 71.45% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8300 | 83.00% |
| CYP3A4 inhibition | - | 0.7542 | 75.42% |
| CYP2C9 inhibition | - | 0.8677 | 86.77% |
| CYP2C19 inhibition | - | 0.8250 | 82.50% |
| CYP2D6 inhibition | - | 0.8983 | 89.83% |
| CYP1A2 inhibition | - | 0.7904 | 79.04% |
| CYP2C8 inhibition | + | 0.7444 | 74.44% |
| CYP inhibitory promiscuity | - | 0.7792 | 77.92% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.9200 | 92.00% |
| Carcinogenicity (trinary) | Non-required | 0.5980 | 59.80% |
| Eye corrosion | - | 0.9889 | 98.89% |
| Eye irritation | - | 0.9715 | 97.15% |
| Skin irritation | - | 0.7925 | 79.25% |
| Skin corrosion | - | 0.9385 | 93.85% |
| Ames mutagenesis | + | 0.6746 | 67.46% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6721 | 67.21% |
| Micronuclear | + | 0.8200 | 82.00% |
| Hepatotoxicity | + | 0.5251 | 52.51% |
| skin sensitisation | - | 0.8786 | 87.86% |
| Respiratory toxicity | + | 0.9000 | 90.00% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.9750 | 97.50% |
| Nephrotoxicity | + | 0.5195 | 51.95% |
| Acute Oral Toxicity (c) | III | 0.5827 | 58.27% |
| Estrogen receptor binding | + | 0.8190 | 81.90% |
| Androgen receptor binding | + | 0.6879 | 68.79% |
| Thyroid receptor binding | + | 0.6317 | 63.17% |
| Glucocorticoid receptor binding | + | 0.8668 | 86.68% |
| Aromatase binding | + | 0.7696 | 76.96% |
| PPAR gamma | + | 0.8115 | 81.15% |
| Honey bee toxicity | - | 0.6983 | 69.83% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5200 | 52.00% |
| Fish aquatic toxicity | - | 0.6027 | 60.27% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase |
623 nM |
Kd |
via Super-PRED
|
| CHEMBL2801 | Q13557 | CaM kinase II delta |
520 nM |
Kd |
via Super-PRED
|
| CHEMBL3829 | Q13555 | CaM kinase II gamma |
823 nM |
Kd |
via Super-PRED
|
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta |
30 nM |
Kd |
via Super-PRED
|
| CHEMBL2695 | Q05397 | Focal adhesion kinase 1 |
436 nM |
Kd |
via Super-PRED
|
| CHEMBL3717 | P08581 | Hepatocyte growth factor receptor |
937 nM |
Kd |
via Super-PRED
|
| CHEMBL3529 | Q14164 | Inhibitor of nuclear factor kappa B kinase epsilon subunit |
528 nM |
Kd |
via Super-PRED
|
| CHEMBL3778 | Q9NWZ3 | Interleukin-1 receptor-associated kinase 4 |
895 nM |
Kd |
via Super-PRED
|
| CHEMBL5754 | Q96L34 | MAP/microtubule affinity-regulating kinase 4 |
8 nM |
Kd |
via Super-PRED
|
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 |
303 nM |
Kd |
via Super-PRED
|
| CHEMBL5330 | Q12851 | Mitogen-activated protein kinase kinase kinase kinase 2 |
631 nM |
Kd |
via Super-PRED
|
| CHEMBL6166 | O95819 | Mitogen-activated protein kinase kinase kinase kinase 4 |
832 nM |
Kd |
via Super-PRED
|
| CHEMBL4852 | Q9Y4K4 | Mitogen-activated protein kinase kinase kinase kinase 5 |
836 nM |
Kd |
via Super-PRED
|
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A |
737 nM |
Kd |
via Super-PRED
|
| CHEMBL1913 | P09619 | Platelet-derived growth factor receptor beta |
436 nM |
Kd |
via Super-PRED
|
| CHEMBL299 | P17252 | Protein kinase C alpha |
35 nM |
Kd |
via Super-PRED
|
| CHEMBL3045 | P05771 | Protein kinase C beta |
19 nM |
Kd |
via Super-PRED
|
| CHEMBL2996 | Q05655 | Protein kinase C delta |
38 nM |
Kd |
via Super-PRED
|
| CHEMBL3384 | Q16512 | Protein kinase N1 |
8 nM |
Kd |
via Super-PRED
|
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta |
191 nM |
Kd |
via Super-PRED
|
| CHEMBL3231 | Q13464 | Rho-associated protein kinase 1 |
955 nM |
Kd |
via Super-PRED
|
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 |
141 nM |
Kd |
via Super-PRED
|
| CHEMBL3981 | O94804 | Serine/threonine-protein kinase 10 |
3 nM |
Kd |
via Super-PRED
|
| CHEMBL4202 | Q9H2G2 | Serine/threonine-protein kinase 2 |
89 nM |
Kd |
via Super-PRED
|
| CHEMBL2185 | Q96GD4 | Serine/threonine-protein kinase Aurora-B |
670 nM |
Kd |
via Super-PRED
|
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 |
16 nM |
Kd |
via Super-PRED
|
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 |
9.88 nM 5.6 nM |
IC50 IC50 |
via Super-PRED
via Super-PRED |
| CHEMBL4598 | Q13043 | Serine/threonine-protein kinase MST1 |
114 nM |
Kd |
via Super-PRED
|
| CHEMBL4708 | Q13188 | Serine/threonine-protein kinase MST2 |
45 nM |
Kd |
via Super-PRED
|
| CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 |
25 nM |
Kd |
via Super-PRED
|
| CHEMBL5699 | Q9H0K1 | Serine/threonine-protein kinase SIK2 |
11 nM |
Kd |
via Super-PRED
|
| CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 |
393 nM |
Kd |
via Super-PRED
|
| CHEMBL4599 | Q07912 | Tyrosine kinase non-receptor protein 2 |
162 nM |
Kd |
via Super-PRED
|
| CHEMBL5251 | Q06187 | Tyrosine-protein kinase BTK |
386 nM |
Kd |
via Super-PRED
|
| CHEMBL3982 | P16591 | Tyrosine-protein kinase FER |
430 nM |
Kd |
via Super-PRED
|
| CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK |
621 nM |
Kd |
via Super-PRED
|
| CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 |
67 nM |
Kd |
via Super-PRED
|
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET |
521 nM |
Kd |
via Super-PRED
|
| CHEMBL2599 | P43405 | Tyrosine-protein kinase SYK |
217 nM |
Kd |
via Super-PRED
|
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.97% | 91.11% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.82% | 94.45% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.05% | 85.14% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.70% | 96.09% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 97.43% | 95.56% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 96.30% | 93.03% |
| CHEMBL2581 | P07339 | Cathepsin D | 95.81% | 98.95% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 95.35% | 85.11% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.89% | 95.89% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 93.19% | 89.00% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 92.95% | 95.83% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 91.37% | 91.07% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 91.02% | 93.99% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 90.85% | 92.88% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 90.67% | 82.50% |
| CHEMBL279 | P35968 | Vascular endothelial growth factor receptor 2 | 90.48% | 95.52% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 90.27% | 94.00% |
| CHEMBL4237 | O75582 | Ribosomal protein S6 kinase alpha 5 | 89.88% | 91.00% |
| CHEMBL1936 | P10721 | Stem cell growth factor receptor | 89.17% | 84.17% |
| CHEMBL3820 | P35557 | Hexokinase type IV | 88.92% | 91.96% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 88.62% | 90.95% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 88.55% | 80.00% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 88.31% | 96.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 88.18% | 97.09% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 87.70% | 96.47% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.63% | 97.14% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 87.16% | 88.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 86.55% | 99.23% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 86.32% | 83.82% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 86.23% | 86.33% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 85.44% | 96.00% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 85.28% | 82.86% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 84.01% | 91.38% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 83.14% | 81.29% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 81.94% | 95.36% |
| CHEMBL2527 | O96017 | Serine/threonine-protein kinase Chk2 | 81.18% | 97.50% |
| CHEMBL1991 | O14920 | Inhibitor of nuclear factor kappa B kinase beta subunit | 80.96% | 97.15% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 80.40% | 91.24% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 72271 |
| LOTUS | LTS0230106 |
| wikiData | Q27074035 |